Literature DB >> 3173380

Synaptonemal complex damage induced by clastogenic and anti-mitotic chemicals: implications for non-disjunction and aneuploidy.

J W Allen1, J B Gibson, P A Poorman, L C Backer, M J Moses.   

Abstract

Mice were treated with mitomycin C, cyclophosphamide, amsacrine, colchicine, or vinblastine sulfate, and meiotic prophase cells analyzed for synaptonemal complex (SC) damage. All test agents caused synaptonemal complex breakage and synapsis irregularities, although propensities for inducing specific types of damage at S-phase or prophase stages varied among the chemicals. The data indicate that SC analysis can reveal chemical-specific alterations to meiotic homologue pairing/synapsis which have not generally been recognized, and which theoretically may be implicated in non-disjunction.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3173380     DOI: 10.1016/0027-5107(88)90020-6

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  4 in total

1.  Novel response to microtubule perturbation in meiosis.

Authors:  Andreas Hochwagen; Gunnar Wrobel; Marie Cartron; Philippe Demougin; Christa Niederhauser-Wiederkehr; Monica G Boselli; Michael Primig; Angelika Amon
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

2.  Synaptonemal complex damage as a measure of genotoxicity at meiosis.

Authors:  J W Allen; P A Poorman; L C Backer; J B Gibson; B Westbrook-Collins; M J Moses
Journal:  Cell Biol Toxicol       Date:  1988-12       Impact factor: 6.691

3.  Effect of estradiol treatment on male mice synaptonemal complexes: difference of sensitivity between neonates and adults.

Authors:  M B Masumbuko; R De Meyer; M Freund
Journal:  Genetica       Date:  1992       Impact factor: 1.082

4.  Exposure to low-dose bisphenol A impairs meiosis in the rat seminiferous tubule culture model: a physiotoxicogenomic approach.

Authors:  Sazan Ali; Gérard Steinmetz; Guillaume Montillet; Marie-Hélène Perrard; Anderson Loundou; Philippe Durand; Marie-Roberte Guichaoua; Odette Prat
Journal:  PLoS One       Date:  2014-09-02       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.